Clinical Trial Search

Primary: Change From Baseline in Pain Related Sleep Interference Scale (PRSIS - Past Week Recall) — 3.1; 2.9; -1.306; -0.357 scores on a scale — p=<0.001

Primary: Quebec Back Pain Disability Scale — 27.9; 27.9; 16.7; 20.3 score on a scale

Primary: Number of Particpants Screened Per Month — 103 participants per month

Primary: Timed Get-Up-And Go — -1.84; -2.15; 1.11 seconds — p=0.08

Primary: Leg Length Inequality — 0.3; 0.58 centemeter

Primary: Visual Analog Scale (VAS) — 5.0; 4.3; 2.8; 4.1 units on a scale — p=.0007

Primary: EuroQoL-5D Visual Acuity Scale (VAS) Score — 47.55; 69.15; 65.35 score on a scale — p=0.005

Primary: Primary Composite Endpoint - Treatment Success — 81.2; 55.7 percentage of subjects — p=<0.0001

Primary: Change From Baseline for Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) at Week 4 — -1.28; -0.90 score on a scale

Primary: Change From Baseline for Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) — -1.24; -1.63 score on a scale

Primary: Safety of Ultrahigh Frequency Treatment: Adverse Event (AE) and Serious AE (SAE) — 5 Participants

Primary: Number of Patients Who Reported Transition From Acute to Chronic Low Back Pain (cLBP) — 312; 318 Participants

Primary: Participants' Level of Low Back Pain-associated Disability as Assessed by Roland Morris Disability Questionnaire (RMDQ) — -1.29; -0.08 score on a scale — p=<0.05

Primary: Symptoms of Chronic Lower Back Pain as Measured With the Visual Analog Scale (VAS) — 26.32; 20.45 percentage of change from baseline to 5

Primary: Time to First Symptoms of Moderate Pain — 2.52; 3.06 minutes

Primary: Oswestry Disability Index Questionnaire(ODI) for Lower Back Pain — 20.45; 19.02 Score on 0-100% scale

Primary: Assessment of Opioid Use Via Subject Report — 47.5; 21.75 morphine milligram equivalent

Primary: Low Back Pain After 6 Weeks of Intervention — 6.50; 6.00; 1.50; 3.50 units on a scale

Primary: Number of Participants Whose Self-reported Degree of Pain on the Visual Analog Scale (VAS) in the Neck and Shoulder Area Decreased by 30% or More From Before to After…

Primary: Change From Baseline for Average Pain Intensity as Measured by the Numeric Rating Scale (NRS) — -1.69; -1.77 score on a scale

Primary: Change From Baseline for Average Pain Intensity as Measured by the NRS — -1.57; -2.09 score on a scale

Primary: Number of Participants With Trophic Ulcer Healing — 11; 28 Participants

Primary: Change in Absolute Claudication Distance (ACD) in Meters From Baseline — -16.8; -6.7; 76.2; -0.9 metres

Primary: Brief Pain Inventory - Pain Interference — -23; -22 units on a scale — p=0.90

Primary: University of Wisconsin Running Injury and Recovery Index Score at Baseline — 10.86; 11.86; 12.14; 9.75 cumulative score on a 9-item scale

Primary: Change From Baseline to 12 Weeks in Brief Pain Inventory 24-hour Average Pain Score — -2.48; -1.80 units on a scale — p=0.001

Primary: West Haven-Yale Multidimensional Pain Inventory (General Activity Subscale) Rating — 35.3; 48.4 score on a scale

Primary: Change in Patient-Reported Outcomes Measurement Information System (PROMIS) Pain Interference 4a Between Week 6 (T2) to Week 15 (T3) — -0.9; -1.8; -1.6; -2.0 score on a…

Primary: Exercise Tolerance Assessed by Measuring Distance (m) Walked in 6-minutes — 388.75; 414.96; 404.29; 419.73 meters

Primary: Participant Adherence With Education + Exercise Visits — 9; 19 participants